AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15657405
Drug: BSA-based dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BSA-based dosing of docetaxel
Trial: 11282808
Drug: Citalopram (20-60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram (20-60 mg)
Trial: 1974071
Drug: Alpidem 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpidem 25 mg
Trial: 1974071
Drug: Alpidem 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpidem 100 mg
Trial: 1974072
Drug: Lorazepam 2
RxNorm normalized name: lorazepam 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam 2 mg (verum)
Trial: 25947329
Drug: LMWH enoxaparin
RxNorm normalized name: enoxaparin
DrugBank: Enoxaparin (DB01225)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LMWH enoxaparin 40 mg subcutaneously once daily plus standard pregnancy surveillance
Trial: 23391727
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (TAU, antidepressant medication) (n = 50)
Trial: 19766640
Drug: Delayed-release mesalamine
RxNorm normalized name: mesalamine Delayed Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed-release mesalamine 4.8 g/day
Trial: 19766640
Drug: Delayed-release mesalamine
RxNorm normalized name: mesalamine Delayed Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed-release mesalamine 2.4 g/day
Trial: 16494585
Drug: Placebo (COX-2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (COX-2 inhibitors)
Trial: 16494585
Drug: Esomeprazole 20
RxNorm normalized name: esomeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 20 mg (COX-2 inhibitors)
Trial: 16494585
Drug: Esomeprazole 40
RxNorm normalized name: esomeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 40 mg (COX-2 inhibitors)
Trial: 1097977
Drug: Oral prostaglandin
RxNorm normalized name: Prostaglandin D2
DrugBank: Prostaglandin D2 (DB02056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prostaglandin E2 (PGE2)
Trial: 6145639
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of oxytocin (Oxy)
Trial: 25496023
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A supplementation (25,000 IU retinyl palmitate daily for 4 months)
Trial: 21809148
Drug: Ketamine 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 0.5 mg/kg bolus
Trial: 16882622
Drug: Radiotherapy (RT)
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Radiotherapy (RT) with a mean dose of 32 Gy (range 30 - 46 Gy)
Trial: 16882622
Drug: Radiotherapy (RT)
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Radiotherapy (RT) with doses of 35 - 46 Gy
Trial: 11329782
Drug: Amrubicin 30
RxNorm normalized name: Valrubicin
DrugBank: Valrubicin (DB00385)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amrubicin 30 mg/day
Trial: 11329782
Drug: Amrubicin 60
RxNorm normalized name: Valrubicin
DrugBank: Valrubicin (DB00385)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amrubicin 60 mg/day
Trial: 11329782
Drug: Amrubicin 90
RxNorm normalized name: Valrubicin
DrugBank: Valrubicin (DB00385)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amrubicin 90 mg/day
Trial: 11329782
Drug: Amrubicin 120
RxNorm normalized name: Valrubicin
DrugBank: Valrubicin (DB00385)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amrubicin 120 mg/day
Trial: 8302687
Drug: Soft gelatin
RxNorm normalized name: Norvir Soft Gelatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soft gelatin capsule (reference)
Trial: 8302687
Drug: Oral solution
RxNorm normalized name: Oral Solution
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral solution under fasting conditions
Trial: 8302687
Drug: Oral solution
RxNorm normalized name: Oral Solution
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral solution mixed with orange juice
Trial: 3090588
Drug: beta blocker
RxNorm normalized name: Beta blocker
FDA approved: no
EMA approved: no
PMDA approved: no
Description: beta blocker (atenolol or propranolol)
Trial: 28474088
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg IV dexamethasone
Trial: 27321368
Drug: 1.5 g
RxNorm normalized name: Vaporizer Vicks 1.5 gal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 g ACCS100 daily for 3 months
Trial: 27321368
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g ACCS100 daily for 3 months
Trial: 24730717
Drug: Low-dose lithium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose lithium carbonate for 4 years
Trial: 8846930
Drug: Transdermal 17
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal 17 beta Estradiol (Estraderm TTS 100 plasters) for 24 weeks, with Chlormadinon 2 mg from day 16 to 28 of the fourth cycle
Trial: 1298792
Drug: Step-back/ultrasound preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Step-back/ultrasound preparation
Trial: 1298792
Drug: Step-back preparation
RxNorm normalized name: Pep-Back
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Step-back preparation
Trial: 6375802
Drug: Cefuroxime (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefuroxime (1.5 g intravenous injection)
Trial: 24786356
Drug: Evacetrapib monotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evacetrapib monotherapy 30 mg
Trial: 24786356
Drug: Evacetrapib monotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evacetrapib monotherapy 100 mg
Trial: 24786356
Drug: Evacetrapib monotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evacetrapib monotherapy 500 mg
Trial: 24786356
Drug: Evacetrapib 100
RxNorm normalized name: Evacetrapib
DrugBank: Evacetrapib (DB11655)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evacetrapib 100 mg in combination with atorvastatin 10 mg
Trial: 18633023
Drug: Overall antiemetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall antiemetic administration
Trial: 22469445
Drug: Rescue medication
RxNorm normalized name: ALLERGENIC EXTRACT, MEADOW FESCUE POLLEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rescue medication use
Trial: 12594633
Drug: Tafenoquine 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tafenoquine 25 mg/week
Trial: 12594633
Drug: Tafenoquine 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tafenoquine 50 mg/week
Trial: 12594633
Drug: Tafenoquine 100
RxNorm normalized name: tafenoquine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tafenoquine 100 mg/week
Trial: 12594633
Drug: Tafenoquine 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tafenoquine 200 mg/week
Trial: 12594633
Drug: Mefloquine 250
RxNorm normalized name: mefloquine 250 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mefloquine 250 mg/week
Trial: 3939672
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg b.i.d. of terfenadine
Trial: 3939672
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg t.i.d. of chlorpheniramine (active control)
Trial: 27733098
Drug: Eyedropper doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eyedropper doses of phenylephrine and tropicamide
Trial: 22337156
Drug: Enhanced format
RxNorm normalized name: formate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enhanced format consent documents (printed on 20-pound, cream-colored bond paper and presented in a blue folio)
Trial: 12034516
Drug: Oral tibolone
RxNorm normalized name: TIBOLONE
DrugBank: Tibolone (DB09070)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral tibolone 2.5 mg per day
Trial: 12034516
Drug: Cyclic combined
RxNorm normalized name: cyclic AMP
DrugBank: Cyclic adenosine monophosphate (DB02527)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclic combined regimen of transdermal oestrogen and progestogen
Trial: 8869019
Drug: Integrelin (glycoprotein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrelin (glycoprotein IIb/IIIa receptor inhibitor)
Trial: 8869019
Drug: Higher doses
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher doses of integrelin
Trial: 373100
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg tienilic acid
Trial: 388400
Drug: 125 mg
RxNorm normalized name: niacin 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 125 mg tienilic acid
Trial: 373100
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg hydrochlorothiazide
Trial: 6309204
Drug: suxamethonium 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: suxamethonium 10 mg
Trial: 6309204
Drug: gallamine 20
RxNorm normalized name: gallamine 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gallamine 20 mg
Trial: 22409922
Drug: Honghua Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Honghua Injection
Trial: 22409922
Drug: Control (routine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (routine Western medicine)
Trial: 8695129
Drug: 0.25 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg/kg mivacurium (divided dose: 0.15 mg/kg followed by 0.1 mg/kg after 30 seconds)
Trial: 8695129
Drug: 1.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg/kg succinylcholine (preceded by 50 micrograms/kg d‐tubocurarine)
Trial: 8695129
Drug: 0.25 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg/kg mivacurium (divided dose)
Trial: 1524174
Drug: Infiltration with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infiltration with 4.4 ml of 1:80,000 adrenaline and 2% lignocaine
Trial: 1524174
Drug: Moffett's solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moffett's solution containing 1 ml of 1:1,000 adrenaline
Trial: 6500458
Drug: Metered dose
RxNorm normalized name: Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metered dose inhaler with small expander
Trial: 6500458
Drug: Metered dose
RxNorm normalized name: Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metered dose inhaler with large expander
Trial: 6500458
Drug: Metered dose
RxNorm normalized name: Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metered dose inhaler without expander
Trial: 29457512
Drug: Perceived network
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perceived network exposure to daily sugar-sweetened beverages
Trial: 29457512
Drug: Perceived network
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perceived network exposure to daily sweets
Trial: 29457512
Drug: Perceived network
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perceived network exposure to weekly vigorous exercise
Trial: 29457512
Drug: Perceived network
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perceived network exposure to weekly moderate exercise
Trial: 23123531
Drug: Hybrid treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hybrid treatment (4 weekly 2-hour sessions)
Trial: 20209697
Drug: Sublingual misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual misoprostol (400 microg every three hours, up to five doses)
Trial: 20209697
Drug: Vaginal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vaginal misoprostol (400 microg every three hours, up to five doses)
Trial: 18722968
Drug: 10 mL
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mL of 1% ropivacaine
Trial: 18722968
Drug: 10 mL
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mL of sterile water
Trial: 16038172
Drug: Prophylaxis with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylaxis with omeprazole 40 mg and metoclopramide 10 mg in group A
Trial: 16038172
Drug: Prophylaxis with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylaxis with omeprazole 40 mg and metoclopramide 10 mg in group B
Trial: 16038172
Drug: Prophylaxis with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylaxis with omeprazole 40 mg and metoclopramide 10 mg in group C
Trial: 16038172
Drug: Outpatient treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Outpatient treatment for GERD in subgroup A1
Trial: 16038172
Drug: No outpatient
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No outpatient treatment for GERD in subgroup A2
Trial: 12185449
Drug: N-acetyl-Ser-Asp-Lys-Pro (AcSDKP;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetyl-Ser-Asp-Lys-Pro (AcSDKP; 1.12 micro g kg(‐1) x min(‐1))
Trial: 8684871
Drug: Brand and
RxNorm normalized name: Betagen brand of Betamethasone and Gentamicin Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brand and generic formulations of cephalexin and erythromycin‐sulfisoxazole
Trial: 8684871
Drug: Generic antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Generic antibiotic suspensions
Trial: 27414973
Drug: Pharmaceutical care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmaceutical care (PhC)
Trial: 18060746
Drug: Ciprofloxacin 250mg
RxNorm normalized name: Ciprofloxacin 250mg/5mL Oral suspension
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 250mg twice a day for 3 days
Trial: 16171664
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg oral rofecoxib preoperatively with IV placebo injection
Trial: 16171664
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg IV ketorolac preoperatively with placebo
Trial: 11322256
Drug: Didanosine (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Didanosine (500 mg daily or 750 mg daily depending on weight)
Trial: 11322256
Drug: Zidovudine (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zidovudine (600 mg daily)
Trial: 11322256
Drug: Didanosine (low-dose)
RxNorm normalized name: ethinyl estradiol
DrugBank: Didanosine (DB00900)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Didanosine (low-dose)
Trial: 11322256
Drug: Didanosine (high-dose)
DrugBank: Didanosine (DB00900)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Didanosine (high-dose)
Trial: 1908745
Drug: Intramuscular Ig
RxNorm normalized name: IG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular Ig 25 mg/kg/wk
Trial: 1908745
Drug: Intramuscular Ig
RxNorm normalized name: IG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular Ig 50 mg/kg/wk
Trial: 24513025
Drug: Citalopram (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram (30 mg)
Trial: 31842388
Drug: Stevia (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stevia (1 g)
Trial: 31842388
Drug: Sugar (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugar (60 g)
Trial: 19700435
Drug: Pre-treatment colonic
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-treatment colonic mucosal gene expression profiles
Trial: 17005066
Drug: Cognitive Stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Stimulation Therapy (CST) combined with 5 mg of donepezil per day for one year.
Trial: 17005066
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg of donepezil per day (control group).
Trial: 8557061
Drug: Cholestyramine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholestyramine (4 g with a liquid meal)
Trial: 8557061
Drug: Cholestyramine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholestyramine (4 g every 2 days for 1 month)
Trial: 8557061
Drug: Liquid meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liquid meal (two egg yolks plus water 200 mL, 50 kJ)
Trial: 1973768
Drug: L-thyroxine (T4,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-thyroxine (T4, 2.5 micrograms/kg body weight daily)
Trial: 1973768
Drug: L-thyroxine (T4,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-thyroxine (T4, 2.5 micrograms/kg body weight daily) + carbimazole (CBZ, 40 mg daily)
Trial: 19114187
Drug: Standard blood
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard blood component therapy
Trial: 10675166
Drug: Placebo therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo therapy (control group)
Trial: 8814201
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (35 mg 20:5(n‐3) + 22:6(n‐3)/(kg body weight.d))
Trial: 8814201
Drug: Flaxseed oil
RxNorm normalized name: Flaxseed Oil
DrugBank: Linseed oil (DB11357)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed oil (35 mg 18:3(n‐3)/(kg body weight.d))
Trial: 8814201
Drug: Olive oil
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olive oil (35 mg 18:1/(kg body weight.d))
Trial: 8814201
Drug: All oil
RxNorm normalized name: TALL OIL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All oil treatments
Trial: 6368906
Drug: Granulocyte transfusions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granulocyte transfusions plus antibiotic therapy (IFCL & CFCL group)
Trial: 6368906
Drug: Granulocyte transfusions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granulocyte transfusions plus antibiotic therapy (FL group)
Trial: 6368906
Drug: Antibiotic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic therapy alone (control group)
Trial: 6368906
Drug: Granulocyte transfusions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granulocyte transfusions plus antibiotic therapy (all transfused patients)
Trial: 31509182
Drug: 200/50 mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200/50 mg dispersible levodopa/benserazide
Trial: 26052813
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy of daily topical antioxidant hydrogel plus excimer light (Group A)
Trial: 24774442
Drug: Intravaginal prasterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravaginal prasterone (DHEA) 0, 3.25 mg, 6.5 mg or 13 mg daily for 12 weeks
Trial: 22815298
Drug: CLP (closed-loop
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CLP (closed-loop control plus 30-μg premeal injections of pramlintide)
Trial: 20051276
Drug: AMA1-C1 vaccine
RxNorm normalized name: C1-INH
DrugBank: Human C1-esterase inhibitor (DB06404)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMA1-C1 vaccine (5 microg)
Trial: 20051276
Drug: AMA1-C1 vaccine
RxNorm normalized name: C1-INH
DrugBank: Human C1-esterase inhibitor (DB06404)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMA1-C1 vaccine (20 microg)
Trial: 20051276
Drug: AMA1-C1 vaccine
RxNorm normalized name: C1-INH
DrugBank: Human C1-esterase inhibitor (DB06404)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMA1-C1 vaccine (80 microg)
Trial: 20051276
Drug: AMA1-C1 vaccine
RxNorm normalized name: C1-INH
DrugBank: Human C1-esterase inhibitor (DB06404)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMA1-C1 vaccine (5 microg and 20 microg)
Trial: 7622915
Drug: Fluconazole 1200
RxNorm normalized name: Fluconazole
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluconazole 1200 mg/day
Trial: 7622915
Drug: Fluconazole 1600
RxNorm normalized name: Fluconazole
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluconazole 1600 mg/day
Trial: 7622915
Drug: Fluconazole 2000
RxNorm normalized name: Fluconazole
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluconazole 2000 mg/day
Trial: 2142394
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg medroxyprogesterone acetate (MPA) twice weekly for 3 months
Trial: 423112
Drug: Personal interview
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Personal interview and capsule count
Trial: 25773309
Drug: Partial weight
RxNorm normalized name: rosin partially dimerized glycerol ester
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Partial weight bearing beginning the same day of conservative treatment (Group 1)
Trial: 11543734
Drug: Fluvoxamine 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvoxamine 300 mg
Trial: 16441740
Drug: 2% minocycline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% minocycline gel
Trial: 30079613
Drug: Emergency endodontic
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Emergency endodontic treatment
Trial: 20847017
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of glucosamine and chondroitin
Trial: 12903700
Drug: Heparin flushes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin flushes (10 U/mL, 1 mL)